preliminary
investigations
pseudomonas
aeruginosa
vaccine
patients
leukemia
cystic
fibrosis
heptavalent
lipopolysaccharide
vaccine
pseudomonas
developed
clinical
trials
revealed
decreased
incidence
sepsis
mortality
due
pseudomonas
vaccinated
patients
burns
vaccinated
certain
groups
immunosuppressed
patients
cancer
may
also
decreased
incidence
death
associated
pseudomonas
trials
parenteral
vaccination
patients
cystic
fibrosis
show
little
benefit
adverse
reactions
vaccine
frequent
often
limit
dose
given
